Local Excision Versus Total Mesorectal Excision In Pathological Complete Response (ypT0-1cN0) Mid- Or Low-Rectal Cancer After Neoadjuvant Therapy
Condition(s):Rectal Cancer; SurgeryLast Updated:June 7, 2018Unknown status
Hide Studies Not Open or Pending
Condition(s):Rectal Cancer; SurgeryLast Updated:June 7, 2018Unknown status
Condition(s):Anesthesia, LocalLast Updated:October 12, 2020Unknown status
Condition(s):Hip Fractures; Surgery; Anesthesia, LocalLast Updated:March 6, 2024Not yet recruiting
Condition(s):Pain; Hip Fractures; Postoperative Pain; Postoperative AnalgesiaLast Updated:August 23, 2023Recruiting
Condition(s):Congenital Heart DiseaseLast Updated:September 26, 2023Recruiting
Condition(s):Local Anesthetic Systemic ToxicityLast Updated:May 12, 2017Completed
Condition(s):Breast Carcinoma; Breast Carcinoma in SituLast Updated:March 28, 2024Recruiting
Condition(s):Erector Spinae Plane Block; Local Anesthetic; Thoracotomy; Postoperative AnalgesiaLast Updated:July 12, 2022Completed
Condition(s):Otosclerosis; Otosclerosis SurgeryLast Updated:April 5, 2022Completed
Condition(s):Regional AnesthesiaLast Updated:May 20, 2020Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.